Analysts at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical ...

Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Monday,RTT News reports.

The Board of Directors of Raymond Limited at their meeting held today i.e., March 22, 2025, have approved to invest an amount ...

Tenax Therapeutics (TENX) has entered into a securities purchase agreement for a private placement financing with RTW Investments, which is ...

Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener ... with a price target consensus of $23.00. TENX market cap is currently $20.59M and ...

Tenax Therapeutics, Inc. announced that the FDA has accepted their plan to expand the Phase 3 LEVEL study of TNX-103 (oral levosimendan), increasing patient enrollment from 152 to 230 to enhance ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LEVEL-2 is a global Phase 3, double-blind, randomized, placebo-controlled study of oral levosimendan in patients with PH-HFpEF. Patients will be randomized to receive an oral dose of levosimendan (2mg ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Police in Savannah are asking that you avoid the area near the Savannah Mall due to a crash that's shut down several lanes.